VAERS reports by lot

Pfizer COVID-19 lot E19267: VAERS reports

22 VAERS reports list lot E19267 as a Pfizer COVID-19 vaccine, received between 2021-02-16 and 2022-03-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
23%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3030%
Gastrointestinal1414%
Neurological1313%
Musculoskeletal1313%
Cardiac / Cardiovascular66%
Respiratory66%
Dermatological (non-injection-site)66%
Thrombotic / Hematological33%
Psychiatric / Neuropsychiatric33%
Allergic / Anaphylactic22%
Injection-site / Local reaction22%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 9).

Florida6
Arizona4
Ohio3
Michigan2
California2
Kentucky1
Nevada1
Oklahoma1
Georgia1

Reports by month received

2021-025
2021-032
2021-042
2021-052
2021-061
2021-071
2021-082
2021-092
2021-111
2021-121
2022-022
2022-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.